Skip to main content
BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
97.15
-0.65 (-0.66%)
At close: Aug 15, 2025, 5:30 PM CET

BioNTech SE Revenue

BioNTech SE had revenue of 260.80M EUR in the quarter ending June 30, 2025, with 102.64% growth. This brings the company's revenue in the last twelve months to 2.88B, up 6.98% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.

Revenue (ttm)
2.88B
Revenue Growth
+6.98%
P/S Ratio
8.10
Revenue / Employee
425.04K
Employees
6,772
Market Cap
23.31B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.38B
Merck KGaA 21.22B
Bayer Aktiengesellschaft 46.17B
Fresenius SE & Co. KGaA 22.28B
Fresenius Medical Care AG 19.52B
Sartorius Aktiengesellschaft 3.47B
Fielmann Group AG 2.33B
Carl Zeiss Meditec AG 2.18B
Revenue Rankings

BioNTech SE News

More News